These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 25978324)

  • 1. Correction: Impact of Age and Gender on the Prevalence and Prognostic Importance of the Metabolic Syndrome and Its Components in Europeans. The MORGAM Prospective Cohort Project.
    Vishram JK; Borglykke A; Andreasen AH; Jeppesen J; Ibsen H; Jørgensen T; Palmieri L; Giampaoli S; Donfrancesco C; Kee F; Mancia G; Cesana G; Kuulasmaa K; Salomaa V; Sans S; Ferrieres J; Dallongeville J; Söderberg S; Arveiler D; Wagner A; Tunstall-Pedoe H; Drygas W; Olsen MH;
    PLoS One; 2015; 10(5):e0128848. PubMed ID: 25978324
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic interactions between cardiovascular risk factors.
    Vishram JK
    Dan Med J; 2014 Jul; 61(7):B4892. PubMed ID: 25123126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do other cardiovascular risk factors influence the impact of age on the association between blood pressure and mortality? The MORGAM Project.
    Vishram JK; Borglykke A; Andreasen AH; Jeppesen J; Ibsen H; Jørgensen T; Broda G; Palmieri L; Giampaoli S; Donfrancesco C; Kee F; Mancia G; Cesana G; Kuulasmaa K; Salomaa V; Sans S; Ferrieres J; Tamosiunas A; Söderberg S; McElduff P; Arveiler D; Pajak A; Olsen MH;
    J Hypertens; 2014 May; 32(5):1025-32; discussion 1033. PubMed ID: 24569413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case-cohort design in practice - experiences from the MORGAM Project.
    Kulathinal S; Karvanen J; Saarela O; Kuulasmaa K
    Epidemiol Perspect Innov; 2007 Dec; 4():15. PubMed ID: 18053196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women.
    Hu G; Qiao Q; Tuomilehto J; Balkau B; Borch-Johnsen K; Pyorala K;
    Arch Intern Med; 2004 May; 164(10):1066-76. PubMed ID: 15159263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome prevalence in a multicultural population in Auckland, New Zealand.
    Gentles D; Metcalf P; Dyall L; Sundborn G; Schaaf D; Black P; Scragg R; Jackson R
    N Z Med J; 2007 Jan; 120(1248):U2399. PubMed ID: 17277815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of metabolic syndrome's components on the development of cardiovascular disease in a Jordanian cohort with metabolic syndrome.
    Haddad FH; Mahafza SM
    Saudi Med J; 2008 Sep; 29(9):1299-305. PubMed ID: 18813416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study.
    Knuiman MW; Hung J; Divitini ML; Davis TM; Beilby JP
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):235-41. PubMed ID: 19238082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The prevalence of metabolic syndrome in a 11 provinces cohort in China].
    Further Study Of Risk Factors For Stroke And Coronary Heart Disease group
    Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Sep; 36(5):298-300. PubMed ID: 12411186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of the metabolic syndrome and its individual components in Brazilian college students.
    de Freitas RW; de Araújo MF; Marinho NB; de Vasconcelos HC; Lima AC; Pereira DC; Almeida PC; Zanetti ML; Damasceno MM
    J Clin Nurs; 2013 May; 22(9-10):1291-8. PubMed ID: 23574292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M; Cortez-Dias N; Martins S; Belo A;
    Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A two fold risk of metabolic syndrome in a sample of patients with schizophrenia: do consanguinity and family history increase risk?
    Bener A; Al-Hamaq AO; Dafeeah EE
    Diabetes Metab Syndr; 2014; 8(1):24-9. PubMed ID: 24661754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic fatty liver disease--a common and benign finding in octogenarian patients.
    Kagansky N; Levy S; Keter D; Rimon E; Taiba Z; Fridman Z; Berger D; Knobler H; Malnick S
    Liver Int; 2004 Dec; 24(6):588-94. PubMed ID: 15566509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A polymorphism in ACE2 is associated with a lower risk for fatal cardiovascular events in females: the MORGAM project.
    Vangjeli C; Dicker P; Tregouet DA; Shields DC; Evans A; Stanton AV;
    J Renin Angiotensin Aldosterone Syst; 2011 Dec; 12(4):504-9. PubMed ID: 21490025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OMEGA study: design, baseline data, metabolic syndrome prevalence in a large-scale observational study of hypertensive patients: The Olmesartan Mega Study to Determine the Relationship between Cardiovascular Endpoints and Blood Pressure Goal Achievement study.
    Teramoto T; Fujita T; Kawamori R; Miyazaki S; Teramukai S; Igarashi M
    Hypertens Res; 2008 Nov; 31(11):2011-7. PubMed ID: 19098372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm.
    Gorter PM; Olijhoek JK; van der Graaf Y; Algra A; Rabelink TJ; Visseren FL;
    Atherosclerosis; 2004 Apr; 173(2):363-9. PubMed ID: 15064114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the prevalence of depressive symptoms and metabolic syndrome. Results of the SOPKARD Project.
    Gil K; Radziłłowicz P; Zdrojewski T; Pakalska-Korcala A; Chwojnicki K; Piwoński J; Ignaszewska-Wyrzykowska A; Załuga L; Mielczarek M; Landowski J; Wyrzykowski B
    Kardiol Pol; 2006 May; 64(5):464-9. PubMed ID: 16752328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in the prevalence of metabolic syndrome and its components among adults with disabilities based on a community health check up data.
    Lin JD; Lin LP; Liou SW; Chen YC; Hsu SW; Liu CT
    Res Dev Disabil; 2013 Jan; 34(1):516-20. PubMed ID: 23085500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome components in relation to risk of cataract extraction: a prospective cohort study of women.
    Lindblad BE; Håkansson N; Philipson B; Wolk A
    Ophthalmology; 2008 Oct; 115(10):1687-92. PubMed ID: 18538408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of metabolic syndrome slows progression of diabetic nephropathy.
    Duran-Perez EG; Almeda-Valdes P; Cuevas-Ramos D; Campos-Barrera E; Muñoz-Hernandez L; Gomez-Perez FJ
    Metab Syndr Relat Disord; 2011 Dec; 9(6):483-9. PubMed ID: 21875335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.